Seattle-based biotech Omeros Corporation has landed a $6.7 million grant from the National Institute on Drug Abuse. Omeros announced the grant on Monday and said it will be provided over three years. The money is going toward testing Omeros’ drug candidate OMS527 for the treatment of cocaine use disorder.
